首页> 外文期刊>OncoTargets and therapy >CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9
【24h】

CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9

机译:Circnol10充当MiR-135a / b-5p的海绵,通过调节KLF9抑制结肠直肠癌进展

获取原文
获取外文期刊封面目录资料

摘要

Background: Circular RNAs (circRNAs) have been documented as key regulators during progression of malignant human cancer, including colorectal cancer (CRC). However, the underlying molecular mechanisms of circNOL10 in CRC remain unclear. Methods: The real-time quantitative polymerase chain reaction was used to quantify the expression of circNOL10, miR-135a-5p, miR-135b-5p, and Krüppel-like factor 9 (KLF9). Kaplan–Meier curve was employed to assess the relationship between survival time of CRC patients and expression level of circNOL10. Cell ability of proliferation was measured by Cell Counting Kit8 and colony formation assays. Cell-cycle analysis was performed using flow cytometry assay. In addition, migration and invasion of CRC cell were examined with transwell analysis. The protein expression level was measured with Western blot assay. The interaction relationship of different molecules was analyzed by bioinformatics database and confirmed by dual-luciferase reporter, RNA immunoprecipitation, and RNA pulldown assay. The functional role of circNOL10 in vivo was determined by xenograft experiment. Results: CircNOL10 was decreased in CRC tissues and cells and was associated with poor outcomes. Gain-of-functional experiment revealed that overexpression of circNOL10 constrained proliferation, cell-cycle progression, migration, and invasion of CRC cells, which was abolished by overexpression of miR-135a-5p or miR-135b-5p. Additionally, miR-135a-5p and miR-135b-5p, targets of circNOL10, regulated KLF9 expression in a negative feedback. Consistently, the results of xenograft experiment suggested that overexpression of circNOL10 inhibited tumor growth in vivo. Conclusion: In summary, our results showed that circNOL10 impeded CRC development by mediating proliferation, cell cycle, migration, and invasion by sponging miR-135a-5p and miR-135b-5p, which provided new understanding for CRC treatment.
机译:背景:在恶性人类癌症的进展过程中被记录为关键调节剂的圆形RNA(Circrna),包括结肠直肠癌(CRC)。然而,CRC中QiCnol10的潜在分子机制仍不清楚。方法:采用实时定量聚合酶链反应量化QiCnol10,miR-135a-5p,miR-135b-5p和krüppel样因子9(klf9)的表达。 Kaplan-Meier曲线被用于评估CRC患者的生存时间与昼夜表达水平的关系。通过细胞计数kit8和菌落形成测定法测量细胞增殖能力。使用流式细胞术测定进行细胞循环分析。此外,通过Transwell分析检查CRC细胞的迁移和侵袭。用蛋白质印迹测定测量蛋白质表达水平。通过生物信息学数据库分析不同分子的相互作用关系,并通过双荧光素酶报告,RNA免疫沉淀和RNA下拉测定证实。通过异种移植物实验确定了QiCnol10在体内的功能作用。结果:CRC组织和细胞中昼夜循环升降率下降,结果不良。功能性实验表明,通过MiR-135a-5p或miR-135b-5p的过度表达消除了Cirnol10约束的增殖,细胞周期进展,迁移和侵袭性的过表达。另外,MiR-135A-5P和MIR-135B-5P,CirNOL10的靶标,在负反馈中调节KLF9表达。始终如一地,异种移植实验的结果表明,昼夜表达抑制体内肿瘤生长。结论:总之,我们的研究结果表明,Circnol10通过海绵MIR-135A-5P和MIR-135B-5P介导的增殖,细胞周期,迁移和入侵,通过对CRC治疗提供了新的了解,通过介导的增殖,细胞周期,迁移和入侵阻碍了CRC开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号